References
- Lands A M, Arnold A, McAuliff J P, et al. Differentiation of receptor systems activated by sympathomimetic amines. Nature 1967; 214: 597–598
- Brittain R T. A comparison of the pharmacology profile of salbutamol with that of isoproterenol, orciprenaline (metaproterenol) and trimetoquinol. Postgrad Med J 1971; 47: 11–16
- Moore P F, Constantine J W, Barth W E. Pirbuterol, a selective beta2 adrenergic bronchodilator. J. Pharmacol Exp Ther 1978; 207: 410
- Kennedy M CS, Simpson W T. Human pharmacological and clinical studies on salbutamol: a specific beta-adrenergic bronchodilator. Br J Dis Chest 1969; 65: 163–174
- Kung M, Croley S W, Phillips B A. Systemic cardiovascular and metabolic effects associated with the inhalation of an increased dose of albuterol. Influence of mouth rinsing and gargling. Chest 1977; 91: 382–387
- Light R W, Taylor R W, George R B. Albuterol and isoproterenol in bronchial asthma. Arch Int Med 1979; 139: 639–643
- Svedmyr N Y, Thiringer G. The effects of salbutamol and isoprenaline on β-receptors in patients with COPD. Postgrad Med J 1971; 47: 44
- Strauss M H, Reeves R A, Smith D L, et al. The role of cardiac beta-1 receptors in the hemodynamic response to a beta2 agonist. Clin Pharmacol Exp Ther 1986; 40: 108–115
- Gibson D G, Coltart D J. Hemodynamic effects of intravenous salbutamol in patients with mitral valve disease: comparison with isoproterenol and atropine. Medicine 1971; 47: 40–44
- Naylor W G, McInnes I. Salbutamol and orciprenaline-induced changes in myocardial function. Cardiovasc Res 1972; 6: 725–733
- Timmis A D, Bergman G, Monoghan M, Jewitt D E. Potential value of oral beta2 adrenoceptor agonists in left ventricular failure. Am J Cardiol 1981; 47: 427
- Crane J, Pearce N E, Flatt A, et al. Prescribed fenoterol and death from asthma in New Zealand. 1981–1983: a case-control study. Lancet 1989; 1: 917–922
- Pierce N, Grainger J, Atkinson M, Crane J, Burgess C, Culling C, Windom H, Beasley R. Case-control study of prescribed fenoterol and death from asthma in New Zealand. 1977–1981. Thorax 1990; 42: 14–20
- O'Donnell S R, Wanstall J C. Evidence that the efficacy (intrinsic activity) of fenoterol is higher than that of salbutamol on β-adrenoceptors in guinea pig trachea. Eur J Pharmacol 1978; 47: 333
- Heel R C, Brogdon R N, Speight T M, Avery G S. Fenoterol: a review of its pharmacological properties and therapeutic efficacy in asthma. Drugs. ADIS Press, Aukland 1978; 3–32
- Tandon M K. Cardiopulmonary effects of fenoterol and salbutamol aerosols. Chest 1980; 77: 429–431
- Littner M R, Tashkin D P, Calvarese B, Bautista M. Acute bronchial and cardiovascular effects of increased doses of pirbuterol acetate aerosol in asthma. Ann Allergy 1982; 42: 14–20
- Crane J, Burgess C, Beasley R. Cardiovascular and hypokalemic effects of inhaled salbutamol, fenoterol and isoprenaline. Thorax 1989; 44: 136–140
- Flatt A, Burgess C, Windom H, Beasley R. The cardiovascular effects of inhaled fenoterol alone and during treatment with oral theophylline. Chest 1989; 96: 1317–1320
- Burges C D, Crane J, Graham A N, Maling T JB. The hemodynamic effects of aminophylline and salbutamol alone and in combination. Clin Pharmacol Ther 1986; 40: 550–553
- Scheinin M, Kaulus M M, Laurikainen E, Allonen H. Hypokalemia and other nonbronchial effects of inhaled fenoterol and salbutamol. A placebo controlled dose-response study in healthy volunteers. Br J Clin Pharmacol 1987; 24: 645–653
- Lemoine H, Schonell H, Kaumann A. Human cardiac beta-adrenergic receptors: subtype heterogeneity delineated by direct radioligand binding. Br J Pharmacol 1988; 95: 55–56
- Lipworth B J, Clark R A, Dhillon D P, McDevitt D G. Subsensitivity of beta-adrenoceptor responses in asthmatic patients taking regular low dose inhaled salbutamol. Eur J Clin Pharmacol 1990; 380: 203–205
- Kaumann A J. Is there a third heart beta-adrenoceptor?. TIPS 1989; 10: 316–320
- Higgens R M, Cookson W OCM, Lane D J, et al. Cardiac arrhythmias caused by nebulized beta-agonist therapy. Lancet 1987; 2: 863–864
- Kenney E L, Troutlein J J, Harbaugh C V, Lambert D, Zelis R F. Ventricular tachycardia after terbutaline. J Am Med Assoc 1978; 240: 2247
- Leitch A G, Clancy L J, Costello J F, Flenley D C. Effect of intravenous infusions of salbutamol on ventilatory response to carbon dioxide and hypoxia on heart rate and plasma potassium in normal men. Br Med J 1976; 1: 365–367